rbd003

Robert B. Den, MD

Contact Dr. Den

111 South 11th Street
Room G-301, Bodine Center
Philadelphia, PA 19107

(215) 955-6702
(215) 955-0412 fax

Most Recent Peer-reviewed Publications

  1. siRNA-Encapsulated Hybrid Nanoparticles Target Mutant K-ras and Inhibit Metastatic Tumor Burden in a Mouse Model of Lung Cancer
  2. MicroRNA-194 promotes prostate cancer metastasis by inhibiting SOCS2
  3. RB loss promotes prostate cancer metastasis
  4. Prognostic outlier genes for enhanced prostate cancer treatment
  5. Multi-institutional Analysis Shows that Low PCAT-14 Expression Associates with Poor Outcomes in Prostate Cancer
  6. Neuropilin-1 is upregulated in the adaptive response of prostate tumors to androgen-targeted therapies and is prognostic of metastatic progression and patient mortality
  7. Transcriptome evaluation of the relation between body mass index and prostate cancer outcomes
  8. Molecular Analysis of Low Grade Prostate Cancer Using a Genomic Classifier of Metastatic Potential
  9. Stromal Gene Expression is Predictive for Metastatic Primary Prostate Cancer
  10. Salvage Radiation Therapy Dose Response for Biochemical Failure of Prostate Cancer After Prostatectomy—A Multi-Institutional Observational Study
  11. ASTRO APEx® and RO-ILS™ are applicable to medical malpractice in radiation oncology
  12. Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysis
  13. Potential Impact on Clinical Decision Making via a Genome-Wide Expression Profiling: A Case Report
  14. Contemporary update of a multi-institutional predictive nomogram for salvage radiotherapy after radical prostatectomy
  15. Reply to Nicola Fossati, Giorgio Gandaglia, Alberto Bossi, Francesco Montorsi, Alberto Briganti's Letter to the Editor re: Stephen J. Freedland, Voleak Choeurng, Lauren Howard, et al. Utilization of a Genomic Classifier for Prediction of Metastasis Following Salvage Radiation Therapy After Radical Prostatectomy. Eur Urol 2016;70:588–96
  16. Radioisotopes in management of metastatic prostate cancer
  17. Utilization of a Genomic Classifier for Prediction of Metastasis Following Salvage Radiation Therapy after Radical Prostatectomy
  18. Integrated classification of prostate cancer reveals a novel luminal subtype with poor outcome
  19. The Missing Pieces in Reporting of Randomized Controlled Trials of External Beam Radiation Therapy Dose Escalation for Prostate Cancer
  20. Decision Support and Shared Decision Making About Active Surveillance Versus Active Treatment Among Men Diagnosed with Low-Risk Prostate Cancer: a Pilot Study